相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors
Vinayak Palve et al.
CELL CHEMICAL BIOLOGY (2022)
Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells
Lavanya H. Palavalli Parsons et al.
ELIFE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Laura Cortesi et al.
TARGETED ONCOLOGY (2021)
PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells
Marit Rasmussen et al.
CELLS (2021)
MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential
Sridevi Challa et al.
CELLS (2021)
Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells
Junji Xing et al.
NATURE COMMUNICATIONS (2021)
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
Joseph M. Gozgit et al.
CANCER CELL (2021)
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants
Laurie B. Schenkel et al.
CELL CHEMICAL BIOLOGY (2021)
Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family
Michael S. Cohen
GENES & DEVELOPMENT (2020)
Dynamics of life expectancy and life span equality
Jose Manuel Aburto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target
Xu Hao et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Integrating DNA-encoded chemical libraries with virtual combinatorial library screening: Optimizing a PARP10 inhibitor
Mike Lemke et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Genome-wide CRISPR synthetic lethality screen identifies a role for the ADP-ribosyltransferase PARP14 in DNA replication dynamics controlled by ATR
Ashna Dhoonmoon et al.
NUCLEIC ACIDS RESEARCH (2020)
Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin
Silvija Bilokapic et al.
NATURE (2020)
Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation
Sara C. Buch-Larsen et al.
CELL REPORTS (2020)
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
Elizaveta E. Alemasova et al.
NUCLEIC ACIDS RESEARCH (2019)
Research Progress on PARP14 as a Drug Target
Wei Qin et al.
FRONTIERS IN PHARMACOLOGY (2019)
PARP3 comes to light as a prime target in cancer therapy
Jose Manuel Rodriguez-Vargas et al.
CELL CYCLE (2019)
Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study
Longfei Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling
Nan Li et al.
NATURE COMMUNICATIONS (2019)
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
Eleonora Arico et al.
CANCERS (2019)
CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI
Wen-Feng Hu et al.
CELL DEATH DISCOVERY (2019)
The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication
Hana Hanzlikova et al.
MOLECULAR CELL (2018)
PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress
Emily M. Schleicher et al.
NUCLEIC ACIDS RESEARCH (2018)
PARP9 is overexpressed in human breast cancer and promotes cancer cell migration
Xinghong Tang et al.
ONCOLOGY LETTERS (2018)
PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation
George E. Ronson et al.
NATURE COMMUNICATIONS (2018)
The Aryl Hydrocarbon Receptor and Tumor immunity
Ping Xue et al.
FRONTIERS IN IMMUNOLOGY (2018)
Rucaparib in ovarian cancer: extending the use of PARP inhibitors in the recurrent disease
Graziela Z. Dal Molin et al.
FUTURE ONCOLOGY (2018)
A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity
Ilsa T. Kirby et al.
CELL CHEMICAL BIOLOGY (2018)
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Rebecca Gupte et al.
GENES & DEVELOPMENT (2017)
Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9
Chun-Song Yang et al.
MOLECULAR CELL (2017)
PARPi focus the spotlight on replication fork protection in cancer
Katharina Schlacher
NATURE CELL BIOLOGY (2017)
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis
Mitsuaki Fujimoto et al.
NATURE COMMUNICATIONS (2017)
PARP1-produced poly-ADP-ribose causes the PARP12 translocation to stress granules and impairment of Golgi complex functions
Giuliana Catara et al.
SCIENTIFIC REPORTS (2017)
Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Tiruveedi Vijaya Lakshmi et al.
CURRENT DRUG TARGETS (2017)
Epigallocatechin-3-gallate enhances ER stress-induced cancer cell apoptosis by directly targeting PARP16 activity
Juanjuan Wang et al.
CELL DEATH DISCOVERY (2017)
Robust immunoglobulin class switch recombination and end joining in Parp9-deficient mice
Isabelle Robert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Genetic Association of PARP15 Polymorphisms with Clinical Outcome of Acute Myeloid Leukemia in a Korean Population
Min Kyung Lee et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2016)
PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting
Karolina N. Dziadkowiec et al.
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY (2016)
PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer
Guangying Qi et al.
ONCOTARGET (2016)
Spermatid Head Elongation with Normal Nuclear Shaping Requires ADP-Ribosyltransferase PARP11 (ARTD11) in Mice
Mirella L. Meyer-Ficca et al.
BIOLOGY OF REPRODUCTION (2015)
Direct visualization of vaults within intact cells by electron cryo-tomography
Cora L. Woodward et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Survivin: A molecular biomarker in cancer
Praveen Kumar Jaiswal et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2015)
A novel role for the mono-ADP-ribosyltransferase PARP14/ARTD8 in promoting homologous recombination and protecting against replication stress
Claudia M. Nicolae et al.
NUCLEIC ACIDS RESEARCH (2015)
Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer
Tanya Todorova et al.
TRENDS IN MOLECULAR MEDICINE (2015)
PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation
Valeria Iansante et al.
NATURE COMMUNICATIONS (2015)
Targeting liver X receptors in cancer therapeutics
Chin-Yo Lin et al.
NATURE REVIEWS CANCER (2015)
Tankyrases: Structure, Function and Therapeutic Implications in Cancer
Teemu Haikarainen et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life
Dragutin Perina et al.
DNA REPAIR (2014)
The ADP-ribosyltransferase PARP10/ARTD10 Interacts with Proliferating Cell Nuclear Antigen ( PCNA) and Is Required for DNA Damage Tolerance
Claudia M. Nicolae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells
Samia B. Bachmann et al.
MOLECULAR CANCER (2014)
Family-wide analysis of poly(ADP-ribose) polymerase activity
Sejal Vyas et al.
NATURE COMMUNICATIONS (2014)
PARP13 regulates cellular mRNA post-transcriptionally and functions as a pro-apoptotic factor by destabilizing TRAILR4 transcript
Tanya Todorova et al.
NATURE COMMUNICATIONS (2014)
BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma
Rosalba Camicia et al.
JOURNAL OF CELL SCIENCE (2013)
Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition
Matteo Berti et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma
A. Barbarulo et al.
ONCOGENE (2013)
A systematic analysis of the PARP protein family identifies new functions critical for cell physiology
Sejal Vyas et al.
NATURE COMMUNICATIONS (2013)
The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
Mike De Vos et al.
BIOCHEMICAL PHARMACOLOGY (2012)
PARP6, a mono(ADP-ribosyl) transferase and a negative regulator of cell proliferation, is involved in colorectal cancer development
Handan Tuncel et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Functional Aspects of PARP1 in DNA Repair and Transcription
Hui Ling Ko et al.
BIOMOLECULES (2012)
Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family
Sung Hoon Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Angiotensin II revisited: new roles in inflammation, immunology and aging
Ariela Benigni et al.
EMBO MOLECULAR MEDICINE (2010)
Toward a unified nomenclature for mammalian ADP-ribosyltransferases
Michael O. Hottiger et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Substrate-Assisted Catalysis by PARP10 Limits Its Activity to Mono-ADP-Ribosylation
Henning Kleine et al.
MOLECULAR CELL (2008)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Vaults: a ribonucleoprotein particle involved in drug resistance?
MH Mossink et al.
ONCOGENE (2003)
Functional aspects of protein mono-ADP-ribosylation
D Corda et al.
EMBO JOURNAL (2003)
分享论文
